By elucidating the ADAR1-miR-142-3p/RIG-I axis, this study provides critical insights into the molecular mechanisms driving NPC progression and offers promising directions for improving diagnosis and treatment. This evidence concerns the gene ADAR and nasopharyngeal carcinoma.